Characteristics of all patients and patients in the surgical site infection sample group
| Mastectomy Patients with Post Surgical Breast Malignancy (January 1, 2014 to June 30, 2021) | Sampling of Patients with Surgical Site Infection (January 1, 2014 to June 30, 2021) | ||
|---|---|---|---|
| CPT code for reconstruction AND Diagnosis code for breast malignancy | N = 1386 | CPT code for reconstruction AND Diagnosis code for breast malignancy | N = 22 |
| Patients with ‘Diabetes’ diagnosis | N = 181 | Patients with ‘Diabetes’ diagnosis | N = 17 |
| Patients with pre-op HgbA1C | N = 268 | Patients with pre-op HgbA1C | N = 22 |
| Patients with Diabetes diagnosis AND pre-op HgbA1C | N = 136 | Patients with Diabetes diagnosis AND pre-op HgbA1C | N = 17 |
| Average value of HgbA1C (%) | 6.74 (N = 268) | Average value of HgbA1C (%) | 6.94 (N = 22) |
| Average value of HgbA1C in patients with Diabetes diagnosis (%) | 7.33 (N = 136) | Average value of HgbA1C in patients with Diabetes diagnosis (%) | 7.34 (N = 17) |
| Average value of HgbA1c in non-diabetic patients (%) | 6.13 (N = 132) | Average value of HgbA1c in non-diabetic patients (%) | 5.58 (N = 5) |
Data are presented as mean values or as column percentage.